ArticleFrontiers in immunology2022

Generation of high affinity ICAM-1-specific nanobodies and evaluation of their suitability for allergy treatment.

Ines Zettl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.